Ads
related to: kadcyla- EMILIA Trial
See EMILIA Clinical Trial
Information on KADCYLA®.
- Important Safety Info
See Full Prescribing Information
Including Boxed Warnings.
- Contact A Representative
Talk With A Representative
To Learn More About KADCYLA®.
- KATHERINE Trial
See Latest KATHERINE Clinical Trial
Information on KADCYLA®.
- Dosing & Admin Guide
Download The Guide To Learn More
About The Dosing Schedule.
- Dosing Recommendations
Learn More About Administering
KADCYLA® To Your Patients.
- EMILIA Trial
Search results
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 9 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 24 cents per share for second-quarter 2022, wider than the...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top
Zacks via Yahoo Finance· 1 year agoPuma Biotechnology PBYI reported fourth-quarter 2022 loss of 12 cents per share, which was wider...
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Ads
related to: kadcyla